The impact of viral load (VL) decay and cumulative VL on CD4 recovery and AIDS after highly-active antiretroviral therapy (HAART) is unknown.Three virologic kinetic parameters (first year and overall exponential VL decay constants, and first year VL slope) and cumulative VL during HAART were estimated for 2,278 patients who initiated HAART in the U.S. Military HIV Natural History Study. CD4 and VL trajectories were computed using linear and nonlinear Generalized Estimating Equations models. Multivariate Poisson and linear regression models were used to determine associations of VL parameters with CD4 recovery, adjusted for factors known to correlate with immune recovery. Cumulative VL higher than the sample median was independently associat...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
Background. We evaluated the effect of maintaining highly active antiretroviral therapy (HAART) on t...
Introduction: Up to 30% of individuals treated with antiretroviral therapy (ART) during chronic HIV ...
(See the editorial commentary by Maggiolo and Leone, on pages 465–467.) Background. Although the kin...
Background: The aim of this study was to examine the relationship between trends in CD4 counts (slop...
Objectives and design: The dynamics of viral decline following the initiation of antiretroviral trea...
Background. Although the kinetics of CD4+ cell counts have been extensively studied in antiretrovira...
OBJECTIVES: Characterizing features of the viral rebound trajectories and identifying host, virologi...
BACKGROUND: Although the kinetics of CD4(+) cell counts have been extensively studied in antiretrovi...
Abstract BACKGROUND: Although the kinetics of CD4(+) cell counts have been extensively studied in ...
<p>Relationship of CD4 slope with viral load in all HIV-infected subjects (A); each symbol represent...
HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretrovi...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
Abstract Background The aim of this study was to examine the relationship between trends in CD4 coun...
HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretrovi...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
Background. We evaluated the effect of maintaining highly active antiretroviral therapy (HAART) on t...
Introduction: Up to 30% of individuals treated with antiretroviral therapy (ART) during chronic HIV ...
(See the editorial commentary by Maggiolo and Leone, on pages 465–467.) Background. Although the kin...
Background: The aim of this study was to examine the relationship between trends in CD4 counts (slop...
Objectives and design: The dynamics of viral decline following the initiation of antiretroviral trea...
Background. Although the kinetics of CD4+ cell counts have been extensively studied in antiretrovira...
OBJECTIVES: Characterizing features of the viral rebound trajectories and identifying host, virologi...
BACKGROUND: Although the kinetics of CD4(+) cell counts have been extensively studied in antiretrovi...
Abstract BACKGROUND: Although the kinetics of CD4(+) cell counts have been extensively studied in ...
<p>Relationship of CD4 slope with viral load in all HIV-infected subjects (A); each symbol represent...
HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretrovi...
Background:CD4(+) cell count is a key measure of HIV disease progression, and the basis of successiv...
Abstract Background The aim of this study was to examine the relationship between trends in CD4 coun...
HIV controllers (HICs) spontaneously maintain HIV viral replication at low level without antiretrovi...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
Background. We evaluated the effect of maintaining highly active antiretroviral therapy (HAART) on t...
Introduction: Up to 30% of individuals treated with antiretroviral therapy (ART) during chronic HIV ...